Caspase-6 as a novel early target in the treatment of Alzheimer's disease

European Journal of Neuroscience

Volumn 37, Issue 12, 2013, Pages 2005-2018

  Leblanc, Andrea C ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Aged individuals; Alzheimer's disease; Caspase 6; Cognitive impairment

Indexed keywords

ALDEHYDE DERIVATIVE; ALPHA TUBULIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ASPARTIC ACID; BENZYLOXYCARBONYLISOLEUCYLGLUTAMYLTHREONYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYLISOLEUCYLGLUTAMYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 9; CASPASE INHIBITOR; INHIBITOR OF APOPTOSIS PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; LAMIN A; PEPTIDE DERIVATIVE; PROTEIN BAX; SYNTHETIC PEPTIDE; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; APOPTOSIS; COGNITIVE DEFECT; CYTOPLASM; DRUG TARGETING; ENTORHINAL CORTEX; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HIPPOCAMPAL CA1 REGION; HUMAN; MICROTUBULE ASSEMBLY; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NERVE FIBER DEGENERATION; NEURITE; NEUROFIBRILLARY TANGLE; NEUROPIL THREAD; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; SEMANTIC MEMORY; SENILE PLAQUE; STRESS; SYNAPTIC TRANSMISSION; UBIQUITINATION; WORKING MEMORY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CASPASE 6; CASPASE INHIBITORS; HUMANS; MICE; NERVE DEGENERATION; NEUROFIBRILLARY TANGLES; NEUROPIL THREADS; PHOSPHORYLATION; PLAQUE, AMYLOID; SIGNAL TRANSDUCTION; TAU PROTEINS;

EID: 84879247889     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.12250     Document Type: Review

References (150)

1. Adrain, C., Murphy, B.M. & Martin, S.J. (2005) Molecular ordering of the caspase activation cascade initiated by the cytotoxic T lymphocyte/natural killer (CTL/NK) protease granzyme B. J. Biol. Chem., 280, 4663-4673.
2. Akpan, N., Serrano-Saiz, E., Zacharia, B.E., Otten, M.L., Ducruet, A.F., Snipas, S.J., Liu, W., Velloza, J., Cohen, G., Sosunov, S.A., Frey, W.H. 2nd., Salvesen, G.S., Connolly, E.S. Jr. & Troy, C.M. (2011) Intranasal delivery of caspase-9 inhibitor reduces caspase-6-dependent axon/neuron loss and improves neurological function after stroke. J. Neurosci., 31, 8894-8904.
3. Albrecht, S., Bourdeau, M., Bennett, D., Mufson, E.J., Bhattacharjee, M. & LeBlanc, A.C. (2007) Activation of caspase-6 in aging and mild cognitive impairment. Am. J. Pathol., 170, 1200-1209.
4. Albrecht, S., Bogdanovic, N., Ghetti, B., Winblad, B. & LeBlanc, A.C. (2009) Caspase-6 activation in familial Alzheimer disease brains carrying amyloid precursor protein or presenilin I or presenilin II mutations. J. Neuropath. Exp. Neur., 68, 1282-1293.
5. Allsopp, T.E., McLuckie, J., Kerr, L.E., Macleod, M., Sharkey, J. & Kelly, J.S. (2000) Caspase 6 activity initiates caspase 3 activation in cerebellar granule cell apoptosis. Cell Death Differ., 7, 984-993.
6. Bennett, D.A., Schneider, J.A., Wilson, R.S., Bienias, J.L. & Arnold, S.E. (2004) Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch. Neurol., 61, 378-384.
7. Bessi, V., Bagnoli, S., Nacmias, B., Tedde, A., Sorbi, S. & Bracco, L. (2010) Semantic dementia associated with mutation V363I in the tau gene. J. Neurol. Sci., 296, 112-114.
8. Braak, H. & Braak, E. (1997) Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging, 18, 351-357.
9. Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H. & Del Tredici, K. (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta. Neuropathol. (Berl.), 112, 389-404.
10. Bugiani, O., Murrell, J.R., Giaccone, G., Hasegawa, M., Ghigo, G., Tabaton, M., Morbin, M., Primavera, A., Carella, F., Solaro, C., Grisoli, M., Savoiardo, M., Spillantini, M.G., Tagliavini, F., Goedert, M. & Ghetti, B. (1999) Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J. Neuropath. Exp. Neur., 58, 667-677.
11. de Calignon, A., Fox, L.M., Pitstick, R., Carlson, G.A., Bacskai, B.J., Spires-Jones, T.L. & Hyman, B.T. (2010) Caspase activation precedes and leads to tangles. Nature, 464, 1201-1204.
12. Canu, N., Dus, L., Barbato, C., Ciotti, M.T., Brancolini, C., Rinaldi, A.M., Novak, M., Cattaneo, A., Bradbury, A. & Calissano, P. (1998) Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis. J. Neurosci., 18, 7061-7074.
13. Cao, Q., Wang, X.J., Liu, C.W., Liu, D.F., Li, L.F., Gao, Y.Q. & Su, X.D. (2012) Inhibitory mechanism of caspase-6 phosphorylation revealed by crystal structures, molecular dynamics simulations, and biochemical assays. J. Biol. Chem., 287, 15371-15379.
14. Carroll, J.C., Iba, M., Bangasser, D.A., Valentino, R.J., James, M.J., Brunden, K.R., Lee, V.M. & Trojanowski, J.Q. (2011) Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy. J. Neurosci., 31, 14436-14449.
15. Choumert, A., Poisson, A., Honnorat, J., Le Ber, I., Camuzat, A., Broussolle, E. & Thobois, S. (2012) G303V tau mutation presenting with progressive supranuclear palsy-like features. Movement Disord., 27, 581-583.
16. Chu, W., Rothfuss, J., Chu, Y., Zhou, D. & Mach, R.H. (2009) Synthesis and in vitro evaluation of sulfonamide isatin Michael acceptors as small molecule inhibitors of caspase-6. J. Med. Chem., 52, 2188-2191.
17. Chung, C.W., Song, Y.H., Kim, I.K., Yoon, W.J., Ryu, B.R., Jo, D.G., Woo, H.N., Kwon, Y.K., Kim, H.H., Gwag, B.J., Mook-Jung, I.H. & Jung, Y.K. (2001) Proapoptotic effects of tau cleavage product generated by caspase-3. Neurobiol. Dis., 8, 162-172.
18. Chung, C.W., Hong, Y.M., Song, S., Woo, H.N., Choi, Y.H., Rohn, T. & Jung, Y.K. (2003) Atypical role of proximal caspase-8 in truncated Tau-induced neurite regression and neuronal cell death. Neurobiol. Dis., 14, 557-566.
19. Cowling, V. & Downward, J. (2002) Caspase-6 is the direct activator of caspase-8 in the cytochrome c-induced apoptosis pathway: absolute requirement for removal of caspase-6 prodomain. Cell Death Differ., 9, 1046-1056.
20. D'Amelio, M., Sheng, M. & Cecconi, F. (2012) Caspase-3 in the central nervous system: beyond apoptosis. Trends Neurosci., 35, 700-709.
21. Deramecourt, V., Lebert, F., Maurage, C.A., Fernandez-Gomez, F.J., Dujardin, S., Colin, M., Sergeant, N., Buee-Scherrer, V., Clot, F., Ber, I.L., Brice, A., Pasquier, F. & Buee, L. (2012) Clinical, neuropathological, and biochemical characterization of the novel tau mutation P332S. J. Alzheimer's Dis., 31, 741-749.
22. Deveraux, Q.L., Leo, E., Stennicke, H.R., Welsh, K., Salvesen, G.S. & Reed, J.C. (1999) Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J., 18, 5242-5251.
23. Dickson, D.W., Wertkin, A., Kress, Y., Ksiezak-Reding, H. & Yen, S.H. (1990) Ubiquitin immunoreactive structures in normal human brains. Distribution and developmental aspects. Lab. Invest., 63, 87-99.
24. Dickson, D.W., Crystal, H.A., Mattiace, L.A., Masur, D.M., Blau, A.D., Davies, P., Yen, S.H. & Aronson, M.K. (1992) Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol. Aging, 13, 179-189.
25. Doostzadeh-Cizeron, J., Yin, S. & Goodrich, D.W. (2000) Apoptosis induced by the nuclear death domain protein p84N5 is associated with caspase-6 and NF-kappa B activation. J. Biol. Chem., 275, 25336-25341.
26. Duyckaerts, C., Delatour, B. & Potier, M.C. (2009) Classification and basic pathology of Alzheimer disease. Acta Neuropathol., 118, 5-36.
27. Edgington, L.E., van Raam, B.J., Verdoes, M., Wierschem, C., Salvesen, G.S. & Bogyo, M. (2012) An optimized activity-based probe for the study of caspase-6 activation. Chem. Biol., 19, 340-352.
28. Ehrnhoefer, D.E., Skotte, N.H., Savill, J., Nguyen, Y.T., Ladha, S., Cao, L.P., Dullaghan, E. & Hayden, M.R. (2011) A quantitative method for the specific assessment of caspase-6 activity in cell culture. PLoS ONE, 6, e27680.
29. Ekici, O.D., Li, Z.Z., Campbell, A.J., James, K.E., Asgian, J.L., Mikolajczyk, J., Salvesen, G.S., Ganesan, R., Jelakovic, S., Grutter, M.G. & Powers, J.C. (2006) Design, synthesis, and evaluation of aza-peptide Michael acceptors as selective and potent inhibitors of caspases-2, -3, -6, -7, -8, -9, and -10. J. Med. Chem., 49, 5728-5749.
30. Ferrer, I. & Planas, A.M. (2003) Signaling of cell death and cell survival following focal cerebral ischemia: life and death struggle in the penumbra. J. Neuropath. Exp. Neur., 62, 329-339.
31. Foley, J.D., Rosenbaum, H. & Griep, A.E. (2004) Temporal regulation of VEID-7-amino-4-trifluoromethylcoumarin cleavage activity and caspase-6 correlates with organelle loss during lens development. J. Biol. Chem., 279, 32142-32150.
32. Fox, N.C., Warrington, E.K., Seiffer, A.L., Agnew, S.K. & Rossor, M.N. (1998) Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study. Brain, 121(Pt 9), 1631-1639.
33. Galvan, V., Chen, S., Lu, D., Logvinova, A., Goldsmith, P., Koo, E.H. & Bredesen, D.E. (2002) Caspase cleavage of members of the amyloid precursor family of proteins. J. Neurochem., 82, 283-294.
34. Galvan, V., Gorostiza, O.F., Banwait, S., Ataie, M., Logvinova, A.V., Sitaraman, S., Carlson, E., Sagi, S.A., Chevallier, N., Jin, K., Greenberg, D.A. & Bredesen, D.E. (2006) Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664. Proc. Natl. Acad. Sci. USA, 103, 7130-7135.
35. Galvan, V., Zhang, J., Gorostiza, O.F., Banwait, S., Huang, W., Ataie, M., Tang, H. & Bredesen, D.E. (2008) Long-term prevention of Alzheimer's disease-like behavioral deficits in PDAPP mice carrying a mutation in Asp664. Behav. Brain Res., 191, 246-255.
36. Gamblin, T.C., Chen, F., Zambrano, A., Abraha, A., Lagalwar, S., Guillozet, A.L., Lu, M., Fu, Y., Garcia-Sierra, F., LaPointe, N., Miller, R., Berry, R.W., Binder, L.I. & Cryns, V.L. (2003) Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc. Natl. Acad. Sci. USA, 100, 10032-10037.
37. Garcia Gil, M.L., Moran, M.A. & Gomez-Ramos, P. (2001) Ubiquitinated granular structures and initial neurofibrillary changes in the human brain. J. Neurol. Sci., 192, 27-34.
38. Geerts, H. (2009) Of mice and men: bridging the translational disconnect in CNS drug discovery. CNS Drugs, 23, 915-926.
39. Gervais, F.G., Xu, D., Robertson, G.S., Vaillancourt, J.P., Zhu, Y., Huang, J., LeBlanc, A., Smith, D., Rigby, M., Shearman, M.S., Clarke, E.E., Zheng, H., Van Der Ploeg, L.H., Ruffolo, S.C., Thornberry, N.A., Xanthoudakis, S., Zamboni, R.J., Roy, S. & Nicholson, D.W. (1999) Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell, 97, 395-406.
40. Gill, R., Soriano, M., Blomgren, K., Hagberg, H., Wybrecht, R., Miss, M.T., Hoefer, S., Adam, G., Niederhauser, O., Kemp, J.A. & Loetscher, H. (2002) Role of caspase-3 activation in cerebral ischemia-induced neurodegeneration in adult and neonatal brain. J. Cerebr. Blood F. Met., 22, 420-430.
41. Glass, D.J. & Arnold, S.E. (2012) Some evolutionary perspectives on Alzheimer's disease pathogenesis and pathology. Alzheimers Dement., 8, 343-351.
42. Gouras, G.K., Xu, H., Gross, R.S., Greenfield, J.P., Hai, B., Wang, R. & Greengard, P. (2000) Testosterone reduces neuronal secretion of Alzheimer's beta-amyloid peptides. Proc. Natl. Acad. Sci. USA, 97, 1202-1205.
43. Gray, D.C., Mahrus, S. & Wells, J.A. (2010) Activation of specific apoptotic caspases with an engineered small-molecule-activated protease. Cell, 142, 637-646.
44. Griffin, W.S., Sheng, J.G., Roberts, G.W. & Mrak, R.E. (1995) Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. J. Neuropath. Exp. Neur., 54, 276-281.
45. Griffin, W.S., Nicoll, J.A., Grimaldi, L.M., Sheng, J.G. & Mrak, R.E. (2000) The pervasiveness of interleukin-1 in Alzheimer pathogenesis: a role for specific polymorphisms in disease risk. Exp. Gerontol., 35, 481-487.
46. Guo, H., Albrecht, S., Bourdeau, M., Petzke, T., Bergeron, C. & LeBlanc, A.C. (2004) Active caspase-6 and caspase-6 cleaved Tau in neuropil threads, neuritic plaques and neurofibrillary tangles of Alzheimer's Disease. Am. J. Pathol., 165, 523-531.
47. Guo, H., Petrin, D., Zhang, Y., Bergeron, C., Goodyer, C.G. & LeBlanc, A.C. (2006) Caspase-1 activation of caspase-6 in human apoptotic neurons. Cell Death Differ., 13, 285-292.
48. Guo, Q., Xie, J., Chang, X. & Du, H. (2001) Prostate apoptosis response-4 enhances secretion of amyloid β peptide 1-42 in human neuroblastoma IMR-32 cells by a caspase-dependent pathway. J. Biol. Chem., 276, 16040-16044.
49. Guyant-Marechal, L., Laquerriere, A., Duyckaerts, C., Dumanchin, C., Bou, J., Dugny, F., Le Ber, I., Frebourg, T., Hannequin, D. & Campion, D. (2006) Valosin-containing protein gene mutations: clinical and neuropathologic features. Neurology, 67, 644-651.
50. Halawani, D. & Latterich, M. (2006) p97: The cell's molecular purgatory? Mol. Cell, 22, 713-717.
51. Halawani, D., Tessier, S., Anzellotti, D., Bennett, D.A., Latterich, M. & LeBlanc, A.C. (2010) Identification of caspase-6-mediated processing of the valosin containing protein (p97) in Alzheimer's disease: a novel link to dysfunction in ubiquitin proteasome system-mediated protein degradation. J. Neurosci., 30, 6132-6142.
52. Halliday, G.M., Song, Y.J., Creasey, H., Morris, J.G., Brooks, W.S. & Kril, J.J. (2006) Neuropathology in the S305S tau gene mutation. Brain, 129, E40.
53. Harigaya, Y., Shoji, M., Shirao, T. & Hirai, S. (1996) Disappearance of actin-binding protein, drebrin, from hippocampal synapses in Alzheimer's disease. J. Neurosci. Res., 43, 87-92.
54. Harris, J.A., Devidze, N., Halabisky, B., Lo, I., Thwin, M.T., Yu, G.Q., Bredesen, D.E., Masliah, E. & Mucke, L. (2010) Many neuronal and behavioral impairments in transgenic mouse models of Alzheimer's disease are independent of caspase cleavage of the amyloid precursor protein. J. Neurosci., 30, 372-381.
55. Heise, C.E., Murray, J., Augustyn, K.E., Bravo, B., Chugha, P., Cohen, F., Giannetti, A.M., Gibbons, P., Hannoush, R.N., Hearn, B.R., Jaishankar, P., Ly, C.Q., Shah, K., Stanger, K., Steffek, M., Tang, Y., Zhao, X., Lewcock, J.W., Renslo, A.R., Flygare, J. & Arkin, M.R. (2012) Mechanistic and structural understanding of uncompetitive inhibitors of caspase-6. PLoS ONE, 7, e50864.
56. Henshall, D.C., Skradski, S.L., Meller, R., Araki, T., Minami, M., Schindler, C.K., Lan, J.Q., Bonislawski, D.P. & Simon, R.P. (2002) Expression and differential processing of caspases 6 and 7 in relation to specific epileptiform EEG patterns following limbic seizures. Neurobiol. Dis., 10, 71-87.
57. Holmes, C., Boche, D., Wilkinson, D., Yadegarfar, G., Hopkins, V., Bayer, A., Jones, R.W., Bullock, R., Love, S., Neal, J.W., Zotova, E. & Nicoll, J.A. (2008) Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet, 372, 216-223.
58. Horowitz, P.M., Patterson, K.R., Guillozet-Bongaarts, A.L., Reynolds, M.R., Carroll, C.A., Weintraub, S.T., Bennett, D.A., Cryns, V.L., Berry, R.W. & Binder, L.I. (2004) Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease. J. Neurosci., 24, 7895-7902.
59. James, K.E., Asgian, J.L., Li, Z.Z., Ekici, O.D., Rubin, J.R., Mikolajczyk, J., Salvesen, G.S. & Powers, J.C. (2004) Design, synthesis, and evaluation of aza-peptide epoxides as selective and potent inhibitors of caspases-1, -3, -6, and -8. J. Med. Chem., 47, 1553-1574.
60. Jentsch, S. & Rumpf, S. (2007) Cdc48 (p97): a 'molecular gearbox' in the ubiquitin pathway?. Trends Biochem. Sci., 32, 6-11.
61. Jiang, C.H., Tsien, J.Z., Schultz, P.G. & Hu, Y. (2001) The effects of aging on gene expression in the hypothalamus and cortex of mice. Proc. Natl. Acad. Sci. USA, 98, 1930-1934.
62. Jonsson, T., Atwal, J.K., Steinberg, S., Snaedal, J., Jonsson, P.V., Bjornsson, S., Stefansson, H., Sulem, P., Gudbjartsson, D., Maloney, J., Hoyte, K., Gustafson, A., Liu, Y., Lu, Y., Bhangale, T., Graham, R.R., Huttenlocher, J., Bjornsdottir, G., Andreassen, O.A., Jonsson, E.G., Palotie, A., Behrens, T.W., Magnusson, O.T., Kong, A., Thorsteinsdottir, U., Watts, R.J. & Stefansson, K. (2012) A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature, 488, 96-99.
63. Kang, E.L., Cameron, A.N., Piazza, F., Walker, K.R. & Tesco, G. (2010) Ubiquitin regulates GGA3-mediated degradation of BACE1. J. Biol. Chem., 285, 24108-24119.
64. Kang, H.J., Yoon, W.J., Moon, G.J., Kim, D.Y., Sohn, S., Kwon, H.J. & Gwag, B.J. (2005) Caspase-3-mediated cleavage of PHF-1 tau during apoptosis irrespective of excitotoxicity and oxidative stress: an implication to Alzheimer's disease. Neurobiol. Dis., 18, 450-458.
65. Klaiman, G., Petzke, T.L., Hammond, J. & LeBlanc, A.C. (2008) Targets of caspase-6 activity in human neurons and Alzheimer disease. Mol. Cell. Proteomics, 7, 1541-1555.
66. Klaiman, G., Champagne, N. & LeBlanc, A.C. (2009) Self-activation of caspase-6 in vitro and in vivo: caspase-6 activation does not induce cell death in HEK293T cells. Biochim. Biophys. Acta, 1793, 592-601.
67. Koegl, M., Hoppe, T., Schlenker, S., Ulrich, H.D., Mayer, T.U. & Jentsch, S. (1999) A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell, 96, 635-644.
68. LeBlanc, A. (1995) Increased production of 4 kDa amyloid beta peptide in serum deprived human primary neuron cultures: possible involvement of apoptosis. J. Neurosci., 15, 7837-7846.
69. LeBlanc, A.C., Liu, H., Goodyer, C., Bergeron, C. & Hammond, J. (1999) Caspase-6 role in apoptosis of human neurons, amyloidogenesis and Alzheimer's disease. J. Biol. Chem., 274, 23426-23436.
70. Lee, A.W., Champagne, N., Wang, X., Su, X.D., Goodyer, C. & Leblanc, A.C. (2010) Alternatively spliced caspase-6B isoform inhibits the activation of caspase-6A. J. Biol. Chem., 285, 31974-31984.
71. Leyva, M.J., Degiacomo, F., Kaltenbach, L.S., Holcomb, J., Zhang, N., Gafni, J., Park, H., Lo, D.C., Salvesen, G.S., Ellerby, L.M. & Ellman, J.A. (2010) Identification and evaluation of small molecule pan-caspase inhibitors in Huntington's disease models. Chem. Biol., 17, 1189-1200.
72. Li, Z., Jo, J., Jia, J.M., Lo, S.C., Whitcomb, D.J., Jiao, S., Cho, K. & Sheng, M. (2010) Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization. Cell, 141, 859-871.
73. MacLachlan, T.K. & El-Deiry, W.S. (2002) Apoptotic threshold is lowered by p53 transactivation of caspase-6. Proc. Natl. Acad. Sci. USA, 99, 9492-9497.
74. Mandelkow, E.M. & Mandelkow, E. (2012) Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb. Perspect. Med., 2, a006247
75. McLaurin, J., Cecal, R., Kierstead, M.E., Tian, X., Phinney, A.L., Manea, M., French, J.E., Lambermon, M.H., Darabie, A.A., Brown, M.E., Janus, C., Chishti, M.A., Horne, P., Westaway, D., Fraser, P.E., Mount, H.T., Przybylski, M. & St George-Hyslop, P. (2002) Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesis. Nat. Med., 8, 1263-1269.
76. Mintzer, R., Ramaswamy, S., Shah, K., Hannoush, R.N., Pozniak, C.D., Cohen, F., Zhao, X., Plise, E., Lewcock, J.W. & Heise, C.E. (2012) A whole cell assay to measure caspase-6 activity by detecting cleavage of lamin A/C. PLoS ONE, 7, e30376.
77. Monnier, P.P., D'Onofrio, P.M., Magharious, M., Hollander, A.C., Tassew, N., Szydlowska, K., Tymianski, M. & Koeberle, P.D. (2011) Involvement of caspase-6 and caspase-8 in neuronal apoptosis and the regenerative failure of injured retinal ganglion cells. J. Neurosci., 31, 10494-10505.
78. Morgan, D., Diamond, D.M., Gottschall, P.E., Ugen, K.E., Dickey, C., Hardy, J., Duff, K., Jantzen, P., DiCarlo, G., Wilcock, D., Connor, K., Hatcher, J., Hope, C., Gordon, M. & Arendash, G.W. (2000) A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature, 408, 982-985.
79. Mori, H., Kondo, J. & Ihara, Y. (1987) Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science, 235, 1641-1644.
80. Morris, M., Maeda, S., Vossel, K. & Mucke, L. (2011) The many faces of tau. Neuron, 70, 410-426.
81. Nikolaev, A., McLaughlin, T., O'Leary, D.D. & Tessier-Lavigne, M. (2009) APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature, 457, 981-989.
82. Noorbakhsh, F., Ramachandran, R., Barsby, N., Ellestad, K.K., Leblanc, A., Dickie, P., Baker, G., Hollenberg, M.D., Cohen, E.A. & Power, C. (2010) MicroRNA profiling reveals new aspects of HIV neurodegeneration: caspase-6 regulates astrocyte survival. FASEB J., 24, 1799-1812.
83. Nyormoi, O., Wang, Z. & Bar-Eli, M. (2003) Sequence-based discovery of a synthetic peptide inhibitor of caspase 6. Apoptosis, 8, 371-376.
84. Olivieri, G., Brack, C., Muller-Spahn, F., Stahelin, H.B., Herrmann, M., Renard, P., Brockhaus, M. & Hock, C. (2000) Mercury induces cell cytotoxicity and oxidative stress and increases beta-amyloid secretion and tau phosphorylation in SHSY5Y neuroblastoma cells. J. Neurochem., 74, 231-236.
85. Olson, N.E., Graves, J.D., Shu, G.L., Ryan, E.J. & Clark, E.A. (2003) Caspase activity is required for stimulated B lymphocytes to enter the cell cycle. J. Immunol., 170, 6065-6072.
86. Orth, K., Chinnaiyan, A.M., Garg, M., Froelich, C.J. & Dixit, V.M. (1996) The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A. J. Biol. Chem., 271, 16443-16446.
87. Ozturk, G., Cengiz, N., Erdogan, E., Him, A., Oguz, E.K., Yenidunya, E. & Aysit, N. (2012) Two distinct types of dying back axonal degeneration in vitro. Neuropath. Appl. Neuro., 39, 362-376.
88. Park, K.H., Hallows, J.L., Chakrabarty, P., Davies, P. & Vincent, I. (2007) Conditional neuronal simian virus 40 T antigen expression induces Alzheimer-like tau and amyloid pathology in mice. J. Neurosci., 27, 2969-2978.
89. Park, K.J., Grosso, C.A., Aubert, I., Kaplan, D.R. & Miller, F.D. (2010) p75NTR-dependent, myelin-mediated axonal degeneration regulates neural connectivity in the adult brain. Nat. Neurosci., 13, 559-566.
90. Pellegrini, L., Passer, B., Tabaton, M., Ganjei, K. & D'Adamio, L. (1999) Alternative, non-secretase processing of Alzheimer's ß-amyloid precursor protein during apoptosis by caspase-6 and -8. J. Biol. Chem., 274, 21011-21016.
91. Perry, G., Friedman, R., Shaw, G. & Chau, V. (1987) Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains. Proc. Natl. Acad. Sci. USA, 84, 3033-3036.
92. Perry, G., Mulvihill, P., Fried, V.A., Smith, H.T., Grundke-Iqbal, I. & Iqbal, K. (1989) Immunochemical properties of ubiquitin conjugates in the paired helical filaments of Alzheimer disease. J. Neurochem., 52, 1523-1528.
93. Petanceska, S.S., Nagy, V., Frail, D. & Gandy, S. (2000) Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain. Neurology, 54, 2212-2217.
94. Querfurth, H.W. & Selkoe, D.J. (1994) Calcium ionophore increases amyloid β peptide production by cultured cells. Biochemistry, 33, 4550-4561.
95. Ramcharitar, J., Afonso, V.A., Albrecht, S., Bennett, D.A. & LeBlanc, A.C. (2013) Caspase-6 activity predicts lower episodic memory ability in aged individuals. Neurobiol. Aging, 34, 1815-1824.
96. Rampon, C., Jiang, C.H., Dong, H., Tang, Y.P., Lockhart, D.J., Schultz, P.G., Tsien, J.Z. & Hu, Y. (2000) Effects of environmental enrichment on gene expression in the brain. Proc. Natl. Acad. Sci. USA, 97, 12880-12884.
97. Richly, H., Rape, M., Braun, S., Rumpf, S., Hoege, C. & Jentsch, S. (2005) A series of ubiquitin binding factors connects CDC48/p97 to substrate multiubiquitylation and proteasomal targeting. Cell, 120, 73-84.
98. Rissman, R.A., Poon, W.W., Blurton-Jones, M., Oddo, S., Torp, R., Vitek, M.P., LaFerla, F.M., Rohn, T.T. & Cotman, C.W. (2004) Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. J. Clin. Invest., 114, 121-130.
99. Rissman, R.A., Staup, M.A., Lee, A.R., Justice, N.J., Rice, K.C., Vale, W. & Sawchenko, P.E. (2012) Corticotropin-releasing factor receptor-dependent effects of repeated stress on tau phosphorylation, solubility, and aggregation. Proc. Natl. Acad. Sci. USA, 109, 6277-6282.
100. Rohn, T.T., Rissman, R.A., Davis, M.C., Kim, Y.E., Cotman, C.W. & Head, E. (2002) Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain. Neurobiol. Dis., 11, 341-354.
101. Rohn, T.T., Kokoulina, P., Eaton, C.R. & Poon, W.W. (2009) Caspase activation in transgenic mice with Alzheimer-like pathology: results from a pilot study utilizing the caspase inhibitor. Q-VD-OPh. Int. J. Clin. Exp. Med., 2, 300-308.
102. Rovelet-Lecrux, A., Hannequin, D., Raux, G., Le Meur, N., Laquerriere, A., Vital, A., Dumanchin, C., Feuillette, S., Brice, A., Vercelletto, M., Dubas, F., Frebourg, T. & Campion, D. (2006) APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat. Genet., 38, 24-26.
103. Ruchaud, S., Korfali, N., Villa, P., Kottke, T.J., Dingwall, C., Kaufmann, S.H. & Earnshaw, W.C. (2002) Caspase-6 gene disruption reveals a requirement for lamin A cleavage in apoptotic chromatin condensation. EMBO J., 21, 1967-1977.
104. Saganich, M.J., Schroeder, B.E., Galvan, V., Bredesen, D.E., Koo, E.H. & Heinemann, S.F. (2006) Deficits in synaptic transmission and learning in amyloid precursor protein (APP) transgenic mice require C-terminal cleavage of APP. J. Neurosci., 26, 13428-13436.
105. Scheff, S.W. & Price, D.A. (2003) Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies. Neurobiol. Aging, 24, 1029-1046.
106. Schneider, J.A. & Bennett, D.A. (2010) Where vascular meets neurodegenerative disease. Stroke, 41, S144-S146.
107. Schoenmann, Z., Assa-Kunik, E., Tiomny, S., Minis, A., Haklai-Topper, L., Arama, E. & Yaron, A. (2010) Axonal degeneration is regulated by the apoptotic machinery or a NAD+-sensitive pathway in insects and mammals. J. Neurosci., 30, 6375-6386.
108. Schwartz, A.L. & Ciechanover, A. (1999) The ubiquitin-proteasome pathway and pathogenesis of human diseases. Annu. Rev. Med., 50, 57-74.
109. Selkoe, D. (1997) Alzheimer's Disease: genotypes, phenotype and treatments. Science, 275, 630-631.
110. Selznick, L., Holtzman, D., Han, B., Gokden, M., Srinivasan, A., Johnson, E. & Roth, K. (1999) In situ immunodetection of neuronal caspase-3 activation in Alzheimer's disease. J. Neuropath. Exp. Neur., 58, 1020-1026.
111. Sheng, M., Sabatini, B.L. & Sudhof, T.C. (2012) Synapses and Alzheimer's disease. Cold Spring Harb. Perspect. Biol., 4, 1-18.
112. Shim, K.S. & Lubec, G. (2002) Drebrin, a dendritic spine protein, is manifold decreased in brains of patients with Alzheimer's disease and Down syndrome. Neurosci. Lett., 324, 209-212.
113. Shiozaki, E.N. & Shi, Y. (2004) Caspases, IAPs and Smac/DIABLO: mechanisms from structural biology. Trends Biochem. Sci., 29, 486-494.
114. Simon, D.J., Weimer, R.M., McLaughlin, T., Kallop, D., Stanger, K., Yang, J., O'Leary, D.D., Hannoush, R.N. & Tessier-Lavigne, M. (2012) A caspase cascade regulating developmental axon degeneration. J. Neurosci., 32, 17540-17553.
115. Sivananthan, S., Lee, A., Goodyer, C.G. & LeBlanc, A.C. (2010) Familial amyloid precursor protein mutants cause caspase-6-dependent but amyloid β-peptide-independent neuronal degeneration in primary human neuron cultures. Cell Death Dis., 1, e100.
116. Skoglund, L., Viitanen, M., Kalimo, H., Lannfelt, L., Jonhagen, M.E., Ingelsson, M., Glaser, A. & Herva, R. (2008) The tau S305S mutation causes frontotemporal dementia with parkinsonism. Eur. J. Neurol., 15, 156-161.
117. Slee, E.A., Harte, M.T., Kluck, R.M., Wolf, B.B., Casiano, C.A., Newmeyer, D.D., Wang, H.G., Reed, J.C., Nicholson, D.W., Alnemri, E.S., Green, D.R. & Martin, S.J. (1999) Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol., 144, 281-292.
118. Slowinski, J., Dominik, J., Uitti, R.J., Ahmed, Z., Dickson, D.D. & Wszolek, Z.K. (2007) Frontotemporal dementia and Parkinsonism linked to chromosome 17 with the N279K tau mutation. Neuropathology, 27, 73-80.
119. Spina, S., Murrell, J.R., Yoshida, H., Ghetti, B., Bermingham, N., Sweeney, B., Dlouhy, S.R., Crowther, R.A., Goedert, M. & Keohane, C. (2007) The novel Tau mutation G335S: clinical, neuropathological and molecular characterization. Acta Neuropathol., 113, 461-470.
120. Spires-Jones, T.L., de Calignon, A., Matsui, T., Zehr, C., Pitstick, R., Wu, H.Y., Osetek, J.D., Jones, P.B., Bacskai, B.J., Feany, M.B., Carlson, G.A., Ashe, K.H., Lewis, J. & Hyman, B.T. (2008) In vivo imaging reveals dissociation between caspase activation and acute neuronal death in tangle-bearing neurons. J. Neurosci., 28, 862-867.
121. Srinivasula, S.M., Fernandes-Alnemri, T., Zangrilli, J., Robertson, N., Armstrong, R.C., Wang, L., Trapani, J.A., Tomaselli, K.J., Litwack, G. & Alnemri, E.S. (1996) The Ced-3/interleukin 1beta converting enzyme-like homolog Mch6 and the lamin-cleaving enzyme Mch2alpha are substrates for the apoptotic mediator CPP32. J. Biol. Chem., 271, 27099-27106.
122. Stadelmann, C., Deckwerth, T., Srinivasan, A., Bancher, C., Bruck, W., Jellinger, K. & Lassmann, H. (1999) Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Am. J. Pathol., 155, 1459-1466.
123. Stanger, K., Steffek, M., Zhou, L., Pozniak, C.D., Quan, C., Franke, Y., Tom, J., Tam, C., Elliott, J.M., Lewcock, J.W., Zhang, Y., Murray, J. & Hannoush, R.N. (2012) Allosteric peptides bind a caspase zymogen and mediate caspase tetramerization. Nat. Chem. Biol., 8, 655-660.
124. Suzuki, A., Kusakai, G., Kishimoto, A., Shimojo, Y., Miyamoto, S., Ogura, T., Ochiai, A. & Esumi, H. (2004) Regulation of caspase-6 and FLIP by the AMPK family member ARK5. Oncogene, 23, 7067-7075.
125. Takahashi, A., Alnemri, E.S., Lazebnik, Y.A., Fernandes-Alnemri, T., Litwack, G., Moir, R.D., Goldman, R.D., Poirier, G.G., Kaufmann, S.H. & Earnshaw, W.C. (1996) Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. Proc. Natl. Acad. Sci. USA, 93, 8395-8400.
126. Tanzi, R.E. & Hyman, B.T. (1991) Alzheimer's mutation. Nature, 350, 564.
127. Tesco, G., Koh, Y.H. & Tanzi, R.E. (2003) Caspase activation increases beta-amyloid generation independently of caspase cleavage of the beta-amyloid precursor protein (APP). J. Biol. Chem., 278, 46074-46080.
128. Tesco, G., Koh, Y.H., Kang, E.L., Cameron, A.N., Das, S., Sena-Esteves, M., Hiltunen, M., Yang, S.H., Zhong, Z., Shen, Y., Simpkins, J.W. & Tanzi, R.E. (2007) Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity. Neuron, 54, 721-737.
129. Thal, D.R., Rub, U., Orantes, M. & Braak, H. (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology, 58, 1791-1800.
130. Tounekti, O., Zhang, Y., Klaiman, G., Goodyer, C.G. & LeBlanc, A. (2004) Proteasomal degradation of caspase-6 in 17beta-estradiol-treated neurons. J. Neurochem., 89, 561-568.
131. Troy, C.M., Friedman, J.E. & Friedman, W.J. (2002) Mechanisms of p75-mediated death of hippocampal neurons. Role of caspases. J. Biol. Chem., 277, 34295-34302.
132. Uribe, V., Wong, B.K., Graham, R.K., Cusack, C.L., Skotte, N.H., Pouladi, M.A., Xie, Y., Feinberg, K., Ou, Y., Ouyang, Y., Deng, Y., Franciosi, S., Bissada, N., Spreeuw, A., Zhang, W., Ehrnhoefer, D.E., Vaid, K., Miller, F.D., Deshmukh, M., Howland, D. & Hayden, M.R. (2012) Rescue from excitotoxicity and axonal degeneration accompanied by age-dependent behavioral and neuroanatomical alterations in caspase-6-deficient mice. Hum. Mol. Genet., 21, 1954-1967.
133. Velazquez-Delgado, E.M. & Hardy, J.A. (2012a) Phosphorylation regulates assembly of the caspase-6 substrate-binding groove. Structure, 20, 742-751.
134. Velazquez-Delgado, E.M. & Hardy, J.A. (2012b) Zinc-mediated allosteric inhibition of caspase-6. J. Biol. Chem., 287, 36000-36011.
135. Verghese, P.B., Sasaki, Y., Yang, D., Stewart, F., Sabar, F., Finn, M.B., Wroge, C.M., Mennerick, S., Neil, J.J., Milbrandt, J. & Holtzman, D.M. (2011) Nicotinamide mononucleotide adenylyl transferase 1 protects against acute neurodegeneration in developing CNS by inhibiting excitotoxic-necrotic cell death. Proc. Natl. Acad. Sci. USA, 108, 19054-19059.
136. Vohra, B.P., Sasaki, Y., Miller, B.R., Chang, J., DiAntonio, A. & Milbrandt, J. (2010) Amyloid precursor protein cleavage-dependent and -independent axonal degeneration programs share a common nicotinamide mononucleotide adenylyltransferase 1-sensitive pathway. J. Neurosci., 30, 13729-13738.
137. Walker, K.R., Kang, E.L., Whalen, M.J., Shen, Y. & Tesco, G. (2012) Depletion of GGA1 and GGA3 mediates postinjury elevation of BACE1. J. Neurosci., 32, 10423-10437.
138. Wang, X.J., Cao, Q., Liu, X., Wang, K.T., Mi, W., Zhang, Y., Li, L.F., LeBlanc, A.C. & Su, X.D. (2010) Crystal structures of human caspase 6 reveal a new mechanism for intramolecular cleavage self-activation. EMBO Rep., 11, 841-847.
139. Watanabe, C., Shu, G.L., Zheng, T.S., Flavell, R.A. & Clark, E.A. (2008) Caspase 6 regulates B cell activation and differentiation into plasma cells. J. Immunol., 181, 6810-6819.
140. Weidemann, A., Paliga, K., Durrwang, U., Reinhard, F.B., Schuckert, O., Evin, G. & Masters, C.L. (1999) Proteolytic processing of the Alzheimer's disease amyloid precursor protein within its cytoplasmic domain by caspase-like proteases. J. Biol. Chem., 274, 5823-5829.
141. Wojcik, C., Rowicka, M., Kudlicki, A., Nowis, D., McConnell, E., Kujawa, M. & DeMartino, G.N. (2006) Valosin-containing protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells. Mol. Biol. Cell, 17, 4606-4618.
142. Xu, H., Gouras, G.K., Greenfield, J.P., Vincent, B., Naslund, J., Mazzarelli, L., Fried, G., Jovanovic, J.N., Seeger, M., Relkin, N.R., Liao, F., Checler, F., Buxbaum, J.D., Chait, B.T., Thinakaran, G., Sisodia, S.S., Wang, R., Greengard, P. & Gandy, S. (1998) Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat. Med., 4, 447-451.
143. Ye, Y., Meyer, H.H. & Rapoport, T.A. (2003) Function of the p97-Ufd1-Npl4 complex in retrotranslocation from the ER to the cytosol: dual recognition of nonubiquitinated polypeptide segments and polyubiquitin chains. J. Cell Biol., 162, 71-84.
144. Zandy, A.J., Lakhani, S., Zheng, T., Flavell, R.A. & Bassnett, S. (2005) Role of the executioner caspases during lens development. J. Biol. Chem., 280, 30263-30272.
145. Zhang, J., Gorostiza, O.F., Tang, H., Bredesen, D.E. & Galvan, V. (2010) Reversal of learning deficits in hAPP transgenic mice carrying a mutation at Asp664: a role for early experience. Behav. Brain Res., 206, 202-207.
146. Zhang, Q., Zhang, X., Chen, J., Miao, Y. & Sun, A. (2009) Role of caspase-3 in tau truncation at D421 is restricted in transgenic mouse models for tauopathies. J. Neurochem., 109, 476-484.
147. Zhang, Y., Goodyer, C. & LeBlanc, A. (2000) Selective and protracted apoptosis in human primary neurons microinjected with active caspase-3, -6, -7, and -8. J. Neurosci., 20, 8384-8389.
148. Zheng, T., Hunot, S., Kuida, K. & Flavell, R. (1999) Caspase knockouts: matters of life and death. Cell Death Differ., 6, 1043-1053.
149. Zheng, T.S. & Flavell, R.A. (2000) Divinations and surprises: genetic analysis of caspase function in mice. Exp. Cell Res., 256, 67-73.
150. Zhu, X., Perry, G., Smith, M.A. & Wang, X. (2012) Abnormal mitochondrial dynamics in the pathogenesis of Alzheimers disease. J. Alzheimers Dis., 33(Suppl 1), S253-S262.